68 related articles for article (PubMed ID: 10483075)
1. Audit of prostate cancer: validity and feasibility of registry-based staging.
Silcocks P; Needham P; Hemsley F
Public Health; 1999 Jul; 113(4):157-60. PubMed ID: 10483075
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
3. Controversies in prostate cancer staging implementation at a tertiary cancer center.
Sexton T; Rodrigues G; Brecevic E; Boyce L; Parrack D; Lock M; D'Souza D
Can J Urol; 2006 Dec; 13(6):3327-34. PubMed ID: 17187696
[TBL] [Abstract][Full Text] [Related]
4. Audit of prostate cancer: lessons learnt for current clinical practice, surrogates for quality of care and standardisation and quality assurance.
Silcocks P; Needham P; Hemsley F
Public Health; 1999 Jul; 113(4):161-4. PubMed ID: 10483076
[TBL] [Abstract][Full Text] [Related]
5. Explaining the race difference in prostate cancer stage at diagnosis.
Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
[TBL] [Abstract][Full Text] [Related]
6. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
7. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.
Taylor SH; Merriman KW; Spiess PE; Pisters L
Cancer; 2006 Feb; 106(3):559-65. PubMed ID: 16369982
[TBL] [Abstract][Full Text] [Related]
8. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
Roach M; Weinberg V; Sandler H; Thompson I
Cancer; 2007 Jan; 109(2):213-20. PubMed ID: 17167758
[TBL] [Abstract][Full Text] [Related]
9. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
[TBL] [Abstract][Full Text] [Related]
10. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
11. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
13. Capturing tumour stage in a cancer information database.
Evans WK; Crook J; Read D; Morriss J; Logan DM
Cancer Prev Control; 1998 Dec; 2(6):304-9. PubMed ID: 10470461
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
15. Population based survival from prostate cancer in Mumbai (Bombay), India.
Yeole BB; Sunny L
Indian J Cancer; 2001; 38(2-4):126-32. PubMed ID: 12593451
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
[TBL] [Abstract][Full Text] [Related]
17. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
[TBL] [Abstract][Full Text] [Related]
19. Determinants of prostate cancer stage in northern New England: USA Franco-American contextual effects.
Parsons MA; Askland KD
Soc Sci Med; 2007 Nov; 65(10):2018-30. PubMed ID: 17689162
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]